Real World Outcomes in Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Undergoing Allogeneic Stem Cell Transplantation–a Single Institution Experience

Researchers performed a retrospective cohort study of Ph+ acute lymphoblastic leukemia patients who received tyrosine kinase inhibitor therapy pre- and post-allogeneic hematopoietic stem cell transplant from April 2007 to November 2019.